In the last months, VANGUARD has explored the support services of Horizon Results Booster (HRB). HRB, an initiative of the European Commission, helps publicly funded projects streamline their innovation processes and maximise their impact, offering services on Portfolio Dissemination &
Last week, the VANGUARD face-to-face meeting took place in Turin, Italy, at the Molecular Biotechnology Center. The event was kindly hosted by Prof. Follenzi from the University of Eastern Piedmont and her team who gathered 21 representatives of the VANGUARD
We are excited to announce the launch of a new Patient Area on the VANGUARD website. While we have previously addressed common patient inquiries through an official letter available on our Outreach page, we have taken a step further. The
The latest research from the VANGUARD project has been featured on the EU research platform together with another EU-funded HemAcure project, highlighting their significant impact on medical science. The HemAcure study on haemophilia A treatment was supported by the VANGUARD
The VANGUARD consortium is proud to join the World Health Organization in commemorating World Health Day 2024 on April 7. This year’s theme, ‘My Health, My Right,’ champions the fundamental right to health services and quality living conditions for everyone
The VANGUARD project is currently in its 52nd month of research and has made progress in all its work packages. Specifically, the research outcomes have resulted in a significant number of dissemination and communication activities, exceeding initial expectations. To date,
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700